High-Throughput Identification, Modeling, and Analysis of Cancer Driver Genes In Vivo

YJ Tang, EG Shuldiner… - Cold Spring …, 2023 - perspectivesinmedicine.cshlp.org
The vast number of genomic and molecular alterations in cancer pose a substantial
challenge to uncovering the mechanisms of tumorigenesis and identifying therapeutic …

Toward a more precise future for oncology

YR Murciano-Goroff, BS Taylor, DM Hyman… - Cancer Cell, 2020 - cell.com
Prospective molecular characterization of cancer has enabled physicians to define the
genomic changes of each patient's tumor in real time and select personalized therapies …

Establishment of a living biobank: Improved guidance of precision cancer care with in vitro and in vivo cancer models

C Pauli, H Moch, MA Rubin - Der Pathologe, 2017 - Springer
Background Precision oncology is a clinical approach aimed towards tailoring treatment
strategies for patients based on the genetic profile of each patient's cancer. The integration …

[HTML][HTML] Preclinical cancer models and biomarkers for drug development: new technologies and emerging tools

M Dhandapani, A Goldman - Journal of molecular biomarkers & …, 2017 - ncbi.nlm.nih.gov
Background and purpose Predicting the efficacy of anticancer therapy is the holy grail of
drug development and treatment selection in the clinic. To achieve this goal, scientists …

Harnessing tumor evolution to circumvent resistance

KL Pogrebniak, C Curtis - Trends in Genetics, 2018 - cell.com
High-throughput sequencing can be used to measure changes in tumor composition across
space and time. Specifically, comparisons of pre-and post-treatment samples can reveal the …

The many faces of gene regulation in cancer: a computational oncogenomics outlook

E Hernández-Lemus, H Reyes-Gopar… - Genes, 2019 - mdpi.com
Cancer is a complex disease at many different levels. The molecular phenomenology of
cancer is also quite rich. The mutational and genomic origins of cancer and their …

A landscape of pharmacogenomic interactions in cancer

F Iorio, TA Knijnenburg, DJ Vis, GR Bignell… - Cell, 2016 - cell.com
Systematic studies of cancer genomes have provided unprecedented insights into the
molecular nature of cancer. Using this information to guide the development and application …

Building patient‐specific models for receptor tyrosine kinase signaling networks

K Ebata, S Yamashiro, K Iida, M Okada - The FEBS Journal, 2022 - Wiley Online Library
Cancer progresses due to changes in the dynamic interactions of multidimensional factors
associated with gene mutations. Cancer research has actively adopted computational …

Genomic medicine frontier in human solid tumors: prospects and challenges

R Dienstmann, J Rodon, J Barretina… - Journal of Clinical …, 2013 - ascopubs.org
Recent discoveries of genomic alterations that underlie and promote the malignant
phenotype, together with an expanded repertoire of targeted agents, have provided many …

Tumor heterogeneity: preclinical models, emerging technologies, and future applications

M Proietto, M Crippa, C Damiani, V Pasquale… - Frontiers in …, 2023 - frontiersin.org
Heterogeneity describes the differences among cancer cells within and between tumors. It
refers to cancer cells describing variations in morphology, transcriptional profiles …